Hutch News

Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100
The value of the combined hormone therapy trial, weighed in lives saved, billions of dollars

The value of the combined hormone therapy trial, weighed in lives saved, billions of dollars

The landmark study that prompted millions of women to stop taking combined hormone therapy resulted in $37.1 billion net economic return, thousands of lives saved, a new study finds
Hutch News - May 05, 2014
Women’s Health Initiative conference draws researchers from around the U.S.

Women’s Health Initiative conference draws researchers from around the U.S.

More than 20 years after WHI began, half of the original 160,000 trial participants are still followed, providing new information as they age
Hutch News - May 01, 2014
Combined hormone therapy increases risk of lobular breast cancer fourfold after just three years of use

Combined hormone therapy increases risk of lobular breast cancer fourfold after just three years of use

Fred Hutchinson Cancer Research Center leads first study designed to evaluate the association between combined HRT use and the risk of lobular breast cancers
Releases - January 15, 2008
Last Modified, August 15, 2019